Asthma prevalence in Olympic summer athletes and the general population: An analysis of three European countries

Burns, Jacob; Mason, Catherine; Mueller, Natalie; Ohlander, Johan; Zock, Jan‐Paul; Drobnic, Franchek; Wolfarth, Bernd; Heinrich, Joachim; Omenaas, Ernst; Stensrud, Trine; Nowak, Dennis; Radon, Katja

doi:10.1016/j.rmed.2015.05.002

Cited by 25 publications

(18 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Athletes signed the consent form and completed the questionnaire. These data were compared with data obtained from German athletes participating in the Olympic Summer Games in Beijing, China 2008 [20,27]. These athletes had answered the same written questionnaire instrument prior to their participation in the Olympic Summer Games 2008.…”

Section: Study Design and Study Participantsmentioning

confidence: 99%

Asthma prevalence in German Olympic athletes: A comparison of winter and summer sport disciplines

Selge

Thomas

Nowak

et al. 2016

Respiratory Medicine

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Study Design and Study Participantsmentioning

confidence: 99%

Asthma prevalence in German Olympic athletes: A comparison of winter and summer sport disciplines

Selge

Thomas

Nowak

et al. 2016

Respiratory Medicine

Self Cite

View full text Add to dashboard Cite

show abstract

“…Given the high prevalence of asthma and asthma‐related conditions, such as exercise‐induced bronchoconstriction, inhaled beta 2 ‐adrenoceptor agonists (beta 2 ‐agonists) are among the most commonly used substances in competitive sports . As for many other substances, the World Anti‐Doping Agency (WADA) has imposed restrictions towards the use of all selective and non‐selective beta 2 ‐agonists both in‐ and out‐ of competition, being listed in the S3‐category (beta 2 ‐agonist specific category) on the 2020 Prohibited List .…”

Section: Introductionmentioning

confidence: 99%

Anabolic and lipolytic actions of beta₂‐agonists in humans and antidoping challenges

Hostrup

Jacobson

Jessen

et al. 2020

Drug Testing and Analysis

View full text Add to dashboard Cite

Inhaled beta 2 -adrenoceptor agonists (beta 2 -agonists) are among the most used substances in competitive sports. The 2020 Prohibited List issued by the World Anti-Doping Agency restricts use of all selective and non-selective beta 2 -agonists in-and out-of competition with few exemptions. Formoterol, salbutamol, and salmeterol are allowed by inhalation within defined dosing limits. These restrictions are in place because supratherapeutic use of beta 2 -agonist has the potential to be anabolic and to enhance performance, as well as due to potential side effects. Despite substantial documentation that beta 2 -agonists exert anabolic and lipolytic actions, these actions are not widely recognized. Furthermore, a common misconception is that the inhaled route does not exert these effects. However, given the high relative systemic bioavailability via the inhaled route, inhalation at high doses can also exert anabolic and lipolytic actions. In this review, we highlight the anabolic and lipolytic actions beta 2agonists can exert, regardless of the type of beta 2 -agonist and the route of administration. The doses needed to provide such effects are also associated with adverse effects and would in most cases be detected in routine doping control. Notwithstanding, the beta 2 -agonist regulations are associated with some challenges and given their ability to induce muscle growth and to enhance performance, it is important to continue developing effective detection strategies to prevent potential misuse of beta 2 -agonists while allowing treatment of asthmatic subjects without causing adverse side effects or ergogenic actions. K E Y W O R D Sanabolic, beta agonists, doping, hypertrophy, muscle growth

show abstract

“…Both medicines are used in the treatment of asthma. Bearing in mind the prevalence of asthma in general population [26,27], but also among athletes [28][29][30], it is presumed that some patients in the doctor's office may be athletes with asthma. However, severe asthma attacks are treated with oral corticosteroids, which are banned in sports.…”

Section: Discussionmentioning

confidence: 99%

Evaluation of knowledge on doping in sports among Serbian general practitioners

Antic

2017

Med pregl

View full text Add to dashboard Cite

Introduction. In the case of illness or injury, athletes, like other patients, seek medical care from general practitioners. Athletes, however, need to be aware of anti-doping regulations. The aim of this study was to evaluate the knowledge and attitudes to doping in sports among general practitioners in Vojvodina. Material and Methods. This cross-sectional study included 276 participants of both sexes and different ages. The data collection was performed using a questionnaire, as a non-standard research technique. The statistical analysis correlated the gathered data in regard sex and age of examinees. Results. Only a small number of respondents is well informed about both the List of Prohibited Doping Substances and Methods and the Law on Prevention of Doping in Sports (10.5% and 8%, respectively). Also, only 2.5% of examinees thought they were qualified to treat athletes. Correct answers that furosemide, pseudoephedrine and tamoxifen are prohibited in sports were given by a small number of respondents (36.6%, 56.9% and 29%, respectively). On the other hand, the fact that inhaled salmeterol, inhaled corticosteroids, enalapril and diclofenac are allowed in sports, was known by 42%, 40.6%, 60.9% and 52.9% of respondents, respectively. Doctors had different attitudes towards doping in sports. Conclusion. The results of this study showed that general practitioners have insufficient knowledge on different aspects of doping in sports. Since they treat all patients, including athletes, their knowledge should be on a higher level in order to avoid accidental doping. The obtained results point to the need for further education of general practitioners on doping in sports.

show abstract

Asthma prevalence in Olympic summer athletes and the general population: An analysis of three European countries

Abstract: Practice of very high endurance and aquatic sports may be associated with increased asthma risks. Athlete participation as such showed no association with asthma risk.

Cited by 25 publications

References 29 publications

Asthma prevalence in German Olympic athletes: A comparison of winter and summer sport disciplines

Asthma prevalence in German Olympic athletes: A comparison of winter and summer sport disciplines

Anabolic and lipolytic actions of beta₂‐agonists in humans and antidoping challenges

Evaluation of knowledge on doping in sports among Serbian general practitioners

Contact Info

Product

Resources

About

Asthma prevalence in Olympic summer athletes and the general population: An analysis of three European countries

Abstract: Practice of very high endurance and aquatic sports may be associated with increased asthma risks. Athlete participation as such showed no association with asthma risk.

Cited by 25 publications

References 29 publications

Asthma prevalence in German Olympic athletes: A comparison of winter and summer sport disciplines

Asthma prevalence in German Olympic athletes: A comparison of winter and summer sport disciplines

Anabolic and lipolytic actions of beta2‐agonists in humans and antidoping challenges

Evaluation of knowledge on doping in sports among Serbian general practitioners

Contact Info

Product

Resources

About

Anabolic and lipolytic actions of beta₂‐agonists in humans and antidoping challenges